Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium avium complex

References

1. Hawkins J. E., Wallace R. J., Brown B. A. Antibacterial susceptibility tests: mycobacteria. In Balows A., Hausler W., Herrmann K., Isenberg H., Shadomy H. (eds) Manual of clinical microbiology 5th edn American Society for Microbiology; Washington: 1991304–339 1138–1152
   [Google Scholar]
2. Inderlied C. B., Kemper C. A., Bermudez L. E. M. The Mycobacterium avium complex. Clin Microbiol Rev 1993; 6:266–310
   [Google Scholar]
3. Hoffner S. E., Klintz L., Olsson-Liljequist B., Bolmström A. Evaluation of E test for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum . J Clin Microbiol 1994; 32:1846–1849
   [Google Scholar]
4. Fabry W., Schmid E. N., Ansorg R. Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium kansasii . Chemotherapy 1995; 41:247–252
   [Google Scholar]
5. DIN 58943, Deutsches Institut für Normierung e. V. Medical microbiology; diagnosis of tuberculosis; methods for the determination of susceptibility of tubercle bacilli to chemotherapeutic agents. 2nd edn Berlin: Koln, Beuth Verlag; 1991264
   [Google Scholar]
6. Inderlied C. B. Antimycobacterial agents: in vitro susceptibility testing, spectrums of activity, mechanisms of action and resistance, and assays for activity in biological fluids. In Lorian V. (ed) Antibiotics in laboratory medicine 3rd edn Baltimore: Williams and Wilkins Co; 1991134–197
   [Google Scholar]
7. Fenlon C. H., Cynamon M. H. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare . Antimicrob Agents Chemother 1986; 29:386–388
   [Google Scholar]
8. Heifets L., Lindholm-Levy R. Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis . Antimicrob Agents Chemother 1989; 33:1298–1301
   [Google Scholar]
9. Leysen D. C., Haemers A., Pattyn S. R. Mycobacteria and the new quinolones. Antimicrob Agents Chemother 1989; 33:1–5
   [Google Scholar]
10. Rastogi N., Goh K. S. Effect of pH on radiometric MICs of clarithromycin against 18 species of Mycobacteria. Antimicrob Agents Chemother 1992; 36:2841–2842
    [Google Scholar]
11. Reeves D. S. The pharmacokinetics of fusidic acid. J Antimicrob Chemother 1987; 20:467–476
    [Google Scholar]
12. Stone M. S., Wallace R. J., Swenson J. M., Thornsberry C., Christensen L. A. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics. Antimicrob Agents Chemother 1983; 24:486–493
    [Google Scholar]
13. Wise R., Lister D., McNulty C. A. M., Griggs D., Andrews J. M. The comparative pharmacokinetics of five quinolones. J Antimicrob Chemother 1986; 18: Suppl D 71–81
    [Google Scholar]
14. Klopman G., Wang S., Jacobs M. R., Bajaksouzian S., Edmonds K., Ellner J. J. Anti-Mycobacterium avium activity of quinolones: in vitro activities. Antimicrob Agents Chemother 1993; 37:1799–1806
    [Google Scholar]
15. Meißner G., Schmiedel A. Mykobakterien und mykobakterielle Erkrankungen. Jena: Gustav Fischer Verlag; 196859
    [Google Scholar]
16. Lee C.-N., Heifets L. B. Determination of minimum inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods. Am Rev Respir Dis 1987; 136:349–352
    [Google Scholar]
17. Bailey W. C., Bass J. B., Hawkins J. E., Kubica G. P., Wallace R. J. Drug susceptibility testing for mycobacteria. Am Thome Soc News 1984; 10:9–10
    [Google Scholar]